Novelgenix Theraps Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVELGENIX THERAPS, and what generic and branded alternatives to NOVELGENIX THERAPS drugs are available?
NOVELGENIX THERAPS has one approved drug.
Drugs and US Patents for Novelgenix Theraps
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novelgenix Theraps | NAPROXEN SODIUM | naproxen sodium | TABLET;ORAL | 207612-001 | Nov 16, 2018 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.